Insulet has begun recalling specific lots of its Omnipod 5 insulin pumps in the U.S. | The diabetes tech company said it is aware of 18 cases of serious complications related to the under-delivery of ...
A tear in the tubing may prevent users from getting full insulin doses. So far 18 people have reported serious issues related to uncontrolled high blood sugar.
The company is recalling certain lots of its insulin patch pumps after finding a small tear in the internal tubing may cause ...
Insulet (Nasdaq:PODD) shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes.
Insulet estimates that the pods involved in this correction represent approximately 1.5% of annual production globally.
Insulet (Nasdaq:PODD) today initiated a voluntary medical device correction for specific lots of Omnipod 5 insulin pump pods.
Senseonics (Nasdaq:SENS) announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM.